Jakob Dupont
Director · Pyxis Oncology, Inc.
IndividualSelling only3 10b5-1 trades
- 2025
- Aug 20, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jakob Dupont files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jakob Dupont?
Jakob Dupont is a corporate insider, tracked as Director of Pyxis Oncology, Inc. (PYXS). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jakob Dupont submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jakob Dupont been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($107K) across all tracked filings.
